VIDEO: Expert discusses three important AML and ALL studies
Click Here to Manage Email Alerts
In this video, Richard M Stone, MD, professor of medicine at Harvard Medical School and director, translation research, adult leukemia program at Dana Farber Institute discusses three studies; one that looked at an irreversible inhibitor of FLT3 in patients with relapsed refractory acute myeloid leukemia (AML), and two studies that looked at approaches to Philadelphia and Philadelphia-like acute lymphoblastic leukemia.
Stone highlighted the importance of the study on Adult Philadelphia-like B-cell ALL.
"This is an important study because, if it is corroborated prospectively, it means that we can identify Philadelphia-like patients fairly easily with a fairly narrow panel of FISH-identifiable lesions.”
Collapse
Levis M, et al. Abstract 7008. Presented at: ASCO Annual Meeting (virtual meeting); 2021; June 4-8, 2021.
Short N, et al. Abstract 7001. Presented at: ASCO Annual Meeting (virtual meeting); 2021; June 4-8, 2021.
Rahman Z, et al. Abstract 7022. Presented at: ASCO Annual Meeting (virtual meeting); 2021; June 4-8, 2021.
Click Here to Manage Email Alerts